CORE A: AdministrationThe Administrative CORE A will oversee all administrative and scientific activities of the UPCI Skin CancerSPORE. Its responsibilities include the coordination of the internal scientific and clinical conduct and allfinancial, regulatory, and informatics components of the research that is planned and in progress. CORE Awill be responsible for internal and external communications regarding the weekly clinical-pathologyconferences of the SPORE investigators, and alternate-weekly clinical-scientific reviews of all protocols ofinvestigation for the SPORE, as well as the monthly data safety reviews. The Administrative CORE willoversee the clinical coordination, data management, and research tumor registry database that serves asannotation of all tissue bank specimens of the protocol-driven Immunological Monitoring and CellularProducts Laboratory Tissue Bank (CORE C), and the overarching Pathology Tissue Bank (CORE B) of thisSPORE. The Administrative CORE will be responsible for all communications with the external and internalScientific Advisory Boards, and NCI personnel. It will submit all reports upon SPORE activities, andcoordinate an annual retreat for the SPORE investigators, as well as the travel of SPORE investigators tothe annual NCI-sponsored SPORE meeting. The Administrative CORE will fund travel of selectedinvestigators to present their research results at scientific conferences, and assist investigators in thepreparation and submission of manuscripts for publication, maintaining the informatics associated with thisSPORE, including an annotated database expanded out of the tumor registry and linked to the protocolbasedand CORE B Tissue Bank resource, that include more than 7000 patients with melanoma and severalthousand tissue specimens collected upon protocols of investigation over the past 20 years. CORE A willmaintain a computerized library of pertinent references of the investigators, and will coordinate activities ofthe SPORE in relation to the UPCI and with the relevant Departmental Chairs responsible for thisInterdisciplinary Program to facilitate the research productivity and complementarities, and synergy within theinstitution an in relation to the other skin SPOREs and the UPCI, and Cooperative Groups. TheAdministrative CORE will interact with the Patient Representatives, and communicate with the NCI ProgramOffice, to ensure that the SPORE guidelines are adhered to and that the mandate for translational researchis accomplished efficiently and in a timely manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA121973-01A1
Application #
7408316
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (O1))
Project Start
2007-10-01
Project End
2012-09-30
Budget Start
2007-10-01
Budget End
2009-07-31
Support Year
1
Fiscal Year
2008
Total Cost
$176,028
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Retseck, Janet; Nasr, Alexis; Lin, Yan et al. (2018) Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma. J Transl Med 16:184
Velásquez, Celestino; Amako, Yutaka; Harold, Alexis et al. (2018) Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1. Front Microbiol 9:713
Butterfield, Lisa H (2018) The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review. Semin Cancer Biol 52:12-15
Hoot, Joyce W; Wang, Li; Kho, Terry et al. (2018) The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides. J Dermatolog Treat 29:272-276
Anderson, Alyce J M; Ferris, Laura K; Binion, David G et al. (2018) Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease. Dig Dis Sci 63:2564-2572
Geskin, Larisa J; Damiano, James J; Patrone, Christina C et al. (2018) Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma. Melanoma Res 28:211-221
Geskin, Larisa J; Akilov, Oleg E; Kwon, Soonyou et al. (2018) Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. Cancer Immunol Immunother 67:423-434
Davar, Diwakar; Wang, Hong; Chauvin, Joe-Marc et al. (2018) Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma. J Clin Oncol :JCO1800632
Anderson, Alyce; Ferris, Laura K; Click, Benjamin et al. (2018) Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients. Dig Dis Sci 63:2729-2739
Zhang, Yi; Liu, Zuqiang; Hao, Xingxing et al. (2018) Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model. Cancer Immunol Immunother 67:353-366

Showing the most recent 10 out of 209 publications